… benefits; and prolonged treatment durations. The new … guideline are for the treatment of
drug-resistant TB (DR-TB), including multidrug-resistant TB (MDR-TB) and isoniazid-resistant TB, …

… ATS/CDC/ERS/IDSA guidelines represents the best available evidence base on which to
assess drugs for treatment of drug-resistant TB (… and linezolid improved treatment success and …

… this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The …
includes recommendations on the treatment of multidrug-resistant TB (MDR-TB) as well as …

Abstract: To interpret the “Treatment of Drug-resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA
Clinical Practice Guideline (ATS Guideline)”, including the drugs, formulating …

… Treatment of drug-resistant tuberculosis: an official ATS/CDC/ERS/IDSA clinical practice
guideline… WHO consolidated guidelines on drug-resistant tuberculosis treatment that delamanid …

… WHO guidelines were based on a modified dataset that expanded on the dataset used to
inform the ATS/CDC/ERS/IDSA clinical practice guideline… The datasets used for both guidelines …

… of drug-resistant TB in 2006 and updated these guidelines in … ATS/CDC/ERS/IDSA guidelines
recommended that the … the treatment and four drugs in the continuation phase [42]. These …

… The regimen proposed by ATS/CDC/ERS/IDSA 7 follows the same order of priority and drug
… that these forms of TB are so difficult to manage (in clinical practice and in programmatic …

… for treating contacts exposed to multidrug-resistant tuberculosis were published in … Treatment
of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. …

… Accelerating development of new shorter TB treatment regimens in anticipation of a
resurgence of multi-drug resistant TB due to the COVID-19 pandemic. Int J Infect Dis. 2021 S1201-…